PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
39.32
+0.88 (2.29%)
Oct 22, 2024, 4:00 PM EDT - Market closed
PTC Therapeutics Employees
As of December 31, 2023, PTC Therapeutics had 1,055 total employees, including 988 full-time and 67 part-time employees. The number of employees decreased by 355 or -25.18% compared to the previous year.
Employees
1,055
Change (1Y)
-355
Growth (1Y)
-25.18%
Revenue / Employee
$853,511
Profits / Employee
-$454,518
Market Cap
3.02B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
Ardent Health Partners | 23,000 |
Bausch Health Companies | 20,270 |
Neogen | 2,917 |
LivaNova | 2,900 |
Astrana Health | 1,800 |
Iovance Biotherapeutics | 557 |
Kymera Therapeutics | 187 |
PTCT News
- 5 days ago - CHMP Maintains Negative Opinion on Translarna™ Reexamination - PRNewsWire
- 8 days ago - PTC Therapeutics Announces FDA Target Regulatory Action Date for Sepiapterin and Lancet Publication of Phase 3 Trial Results - PRNewsWire
- 14 days ago - PTC Therapeutics Announces Positive Results from Long-Term Treatment Studies and Updates on Regulatory Progress for Vatiquinone Friedreich Ataxia Program - PRNewsWire
- 21 days ago - PTC Therapeutics Announces FDA Acceptance for Filing of NDA for Sepiapterin for the Treatment of Pediatric and Adult Phenylketonuria Patients - PRNewsWire
- 26 days ago - FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program - PRNewsWire
- 5 weeks ago - PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 5 weeks ago - PTC Therapeutics: Positive HD Data Along With NDA Submission Brings Further Value - Seeking Alpha
- 7 weeks ago - PTC Therapeutics to Participate at Upcoming Investor Conferences - PRNewsWire